HAVN Life Sciences Inc (fra:5NP0) Share Price

Company Profile

Business description
HAVN Life Sciences Inc is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, it offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.
Contact
605 - 130 Brew Street
Port MoodyBCV3H 0E3
CAN
T: +1 604 639-2143
https://www.havnlife.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 April 2025
Employees
6

Recommended

Our view on the potential acquisition.

Shaun Ler | 18 March 2025

4 factors that led to the incredible returns of Philip Morris.

Shani Jayamanne | 17 March 2025

These undervalued stocks of high-quality companies could be attractive investments today.

Margaret Giles | 17 March 2025

Index	Last price	Change	% Change
All Ordinaries	8,055.30	34.60	-0.43%
CAC 40	8,171.47	56.90	0.70%
DAX 40	23,288.06	92.64	-0.40%
Dow JONES (US)	41,964.63	383.32	0.92%
FTSE 100	8,706.66	1.43	0.02%
HKSE	24,771.14	30.57	0.12%
NASDAQ	17,750.79	246.67	1.41%
Nikkei 225	37,751.88	93.54	-0.25%
NZX 50 Index	12,078.21	32.28	0.27%
S&P 500	5,675.29	60.63	1.08%
S&P/ASX 200	7,828.30	32.10	-0.41%
SSE Composite Index	3,426.43	3.33	-0.10%